Morgan Stanley has maintained an ‘Equal Weight’ rating on Dabur, with a target price of ₹531/share, reflecting a marginal upside of 1.3% from the current market price (CMP) of ₹524.00.
The Q3 update highlighted consolidated revenue growth in the low single digits, slightly below estimates. A delayed winter season negatively impacted the healthcare portfolio and beverages segment. However, rural markets outperformed urban areas, showcasing resilience in Dabur’s rural-focused strategy.
Morgan Stanley views the mixed performance as aligned with broader market trends, with recovery hinging on seasonal normalization and rural demand sustainability.
Disclaimer: The above analysis is based on inputs provided and is for informational purposes only. It does not constitute financial advice. Readers are advised to consult their financial advisors before making any investment decisions.
